Article ID Journal Published Year Pages File Type
5880218 The Journal of Pain 2014 6 Pages PDF
Abstract
This article showed that INFS and FPNS in doses proportional to basal opioid regimen are equally safe and effective for the management of breakthrough pain in cancer patients. These data provide new insights on the use of nasal preparations of fentanyl.
Keywords
Related Topics
Life Sciences Neuroscience Neurology
Preview
Intranasal Fentanyl Versus Fentanyl Pectin Nasal Spray for the Management of Breakthrough Cancer Pain in Doses Proportional to Basal Opioid Regimen
Authors
, , , ,